Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

2.9%

3 terminated/withdrawn out of 104 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

14 trials in Phase 3/4

Results Transparency

13%

2 of 15 completed trials have results

Key Signals

35 recruiting2 with results

Enrollment Performance

Analytics

N/A
40(51.9%)
Phase 1
12(15.6%)
Phase 3
8(10.4%)
Phase 4
6(7.8%)
Early Phase 1
6(7.8%)
Phase 2
5(6.5%)
77Total
N/A(40)
Phase 1(12)
Phase 3(8)
Phase 4(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (104)

Showing 20 of 104 trials
NCT07562984Not ApplicableNot Yet Recruiting

A Bio-Psycho-Social Medical Model-Based Study on Adolescent Female HPV Vaccination Behavior and Comprehensive Intervention

Role: lead

NCT07558954Not ApplicableNot Yet Recruiting

Application Construction and Effect Evaluation of Family-empowered Pulmonary Rehabilitation in School-age Children With Asthma

Role: lead

NCT07549425Active Not Recruiting

Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children

Role: lead

NCT07530133Not ApplicableNot Yet Recruiting

Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery

Role: collaborator

NCT07529028Not ApplicableNot Yet Recruiting

Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy

Role: collaborator

NCT07507201Early Phase 1Recruiting

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Role: lead

NCT07499154Phase 4Not Yet Recruiting

Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery

Role: lead

NCT07496541Not Yet Recruiting

Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis

Role: lead

NCT07490041Early Phase 1Recruiting

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Role: lead

NCT07483749Not Yet Recruiting

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

Role: lead

NCT03948048Recruiting

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

Role: collaborator

NCT07462299Not ApplicableNot Yet Recruiting

NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy

Role: lead

NCT07452380Recruiting

The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma

Role: lead

NCT07298928Not ApplicableNot Yet Recruiting

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

Role: lead

NCT07450872Recruiting

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

Role: lead

NCT06539624Not ApplicableRecruiting

Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

Role: lead

NCT07435103Phase 1Not Yet Recruiting

Xenon Therapy for Children With Autism Spectrum Disorder

Role: lead

NCT07437183Not ApplicableNot Yet Recruiting

A Multicenter Clinical Study on the Optimization of Timing and Efficacy Evaluation of Bronchoscopic Intervention in Pediatric Severe Pneumonia

Role: lead

NCT07437170Phase 2Active Not Recruiting

Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

Role: lead

NCT07045844Not ApplicableNot Yet Recruiting

Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants

Role: lead